Skip to main content
. 2022 Sep 15;17(9):e0274423. doi: 10.1371/journal.pone.0274423

Table 4. Prevalence of 3GCr and carbapenem-resistant pathogens among patients with community-acquired UTI.

Covariates* 3GCr n (%) Age (yrs) (Mean±SD) OR (CI) Covariates* CarbR n (%) Age (yrs) (Mean±SD) OR (CI)
Adult (n = 521) Adult (n = 521)
Male (n = 107) 77 (72) 58.88±12.97 1 Male (n = 107) 5 (5) 62.40±7.64 1
Female (n = 414) 271 (65) 53.27±14.17 0.74 (0.46–1.18) Female (n = 414) 20 (5) 53.15±16.58 1.04 (0.38–2.83)
Adolescent (n = 8) Adolescent (n = 8)
Male (n = 2) 1 (50) - 1 Male (n = 2) 1 (50) - -
Female (n = 6) 4 (67) 14.00±3.46 2 (0.07–51.59) Female (n = 6) 0 - -
Child (n = 58) Child (n = 58)
Male (n = 21) 15 (71) 2.00±1.85 1 Male (n = 21) 2 (10) 1.23±0.86 1
Female (n = 37) 24 (65) 4.67±3.03 0.74 (0.23–2.36) Female (n = 37) 2 (5) 8±1.41 0.54 (0.07–4.17)

CarbR, carbapenem resistant; n, number; 3GCr, 3rd generation cephalosporin resistant

*One isolate represents one patient. A total of 587 Gram-negative isolates were tested for susceptibility against third-generation cephalosporin and carbapenem antibiotics.